Literature DB >> 7596464

Effects of bromocriptine on staining indices of Ki-67 and proliferating cell nuclear antigen, and nucleolar organizer region number in pituitary adenomas.

S M Ekramullah1, Y Saitoh, T Ohnishi, N Arita, T Taki, T Hayakawa.   

Abstract

The effects of bromocriptine (CB-154) on the proliferative capacities of prolactinoma and somatotropinoma were investigated by immunocytochemical staining indices of proliferating cell nuclear antigen (PCNA) and Ki-67 (with MIB-1 antibody), and silver staining of nucleolar organizer region (NOR) number in histological sections. Patients with prolactinoma and somatotropinoma were divided into two groups: no preoperative treatment (control group), and treated with CB-154 for 2 weeks before adenomectomy (CB-154 group). The prolactinoma CB-154 group showed a significantly lower PCNA staining index (n = 6, 13.1 +/- 2.0%) and Ki-67 staining index (n = 6, 0.2 +/- 0.03%) than the control group (n = 4, 27.1 +/- 2.1%; n = 8, 1.9 +/- 0.5%; respectively) (p < 0.01). The somatotropinoma CB-154 group showed a significantly lower Ki-67 staining index (n = 5, 0.7 +/- 0.07%) than the control group (n = 11, 1.2 +/- 0.2%) (p < 0.05), but there was no significant difference in PCNA staining index (control: n = 5, 19.1 +/- 2.8% vs. CB-154: n = 5, 20.2 +/- 1.4%). However, variable intensities of PCNA staining between the cells were observed, resulting in an extraordinarily high staining index. NOR numbers did not vary significantly between the two prolactinoma groups (control: n = 4, 2.0 +/- 0.3 vs. CB-154: n = 6, 1.7 +/- 0.1) and two somatotropinoma groups (control: n = 5, 1.3 +/- 0.1 vs. CB-154: n = 5, 1.4 +/- 0.2).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596464     DOI: 10.2176/nmc.35.221

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  3 in total

1.  The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas.

Authors:  S M Ekramullah; Y Saitoh; N Arita; T Ohnishi; T Hayakawa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.

Authors:  Ludmila Astaf'eva; Ludmila Shishkina; Pavel Kalinin; Boris Kadashev; Galina Melnichenko; Dariia Tserkovnay; Oleg Sharipov
Journal:  Asian J Neurosurg       Date:  2020-05-29

3.  Effect of Dopamine Agonists on Lactotroph Adenomas of the Human Pituitary.

Authors:  Lucia Stefaneanu; Kalman Kovacs; Bernd W. Scheithauer; George Kontogeorgos; Darren L. Riehle; Thomas J. Sebo; David Murray; Sergio Vidal; Ami Tran; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.